{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:14:56Z","timestamp":1794251696707,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-50747-6","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:49:51Z","timestamp":1724406591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuka","family":"Nishibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suishin","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Nakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodaka","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeka","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-4630","authenticated-orcid":false,"given":"Daigo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utano","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nagakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7084-9734","authenticated-orcid":false,"given":"Akihiro","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"50747_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","volume":"19","author":"T Nemeth","year":"2020","unstructured":"Nemeth, T., Sperandio, M. & Mocsai, A. Neutrophils as emerging therapeutic targets. Nat. Rev. Drug Discov. 19, 253\u2013275 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"50747_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.biocel.2007.11.008","volume":"40","author":"CT Pham","year":"2008","unstructured":"Pham, C. T. Neutrophil serine proteases fine-tune the inflammatory response. Int. J. Biochem. Cell Biol. 40, 1317\u20131333 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"50747_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pharmthera.2018.05.011","volume":"190","author":"B Korkmaz","year":"2018","unstructured":"Korkmaz, B. et al. Therapeutic targeting of cathepsin C: from pathophysiology to treatment. Pharm. Ther. 190, 202\u2013236 (2018).","journal-title":"Pharm. Ther."},{"key":"50747_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2021","unstructured":"Mutua, V. & Gershwin, L. J. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin. Rev. Allergy Immunol. 61, 194\u2013211 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"50747_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"50747_CR6","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","volume":"189","author":"MJ Kaplan","year":"2012","unstructured":"Kaplan, M. J. & Radic, M. Neutrophil extracellular traps: double-edged swords of innate immunity. J. Immunol. 189, 2689\u20132695 (2012).","journal-title":"J. Immunol."},{"key":"50747_CR7","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1002\/art.34619","volume":"64","author":"D Nakazawa","year":"2012","unstructured":"Nakazawa, D. et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 64, 3779\u20133787 (2012).","journal-title":"Arthritis Rheum."},{"key":"50747_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fimmu.2016.00236","volume":"7","author":"AS Kimball","year":"2016","unstructured":"Kimball, A. S., Obi, A. T., Diaz, J. A. & Henke, P. K. The emerging role of NETs in venous thrombosis and immunothrombosis. Front. Immunol. 7, 236 (2016).","journal-title":"Front. Immunol."},{"key":"50747_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nchembio.496","volume":"7","author":"A Hakkim","year":"2011","unstructured":"Hakkim, A. et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat. Chem. Biol. 7, 75\u201377 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"50747_CR10","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","volume":"133","author":"FVS Castanheira","year":"2019","unstructured":"Castanheira, F. V. S. & Kubes, P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood 133, 2178\u20132185 (2019).","journal-title":"Blood"},{"key":"50747_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1083\/jcb.200806072","volume":"184","author":"Y Wang","year":"2009","unstructured":"Wang, Y. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J. Cell Biol. 184, 205\u2013213 (2009).","journal-title":"J. Cell Biol."},{"key":"50747_CR12","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"50747_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","volume":"8","author":"KD Metzler","year":"2014","unstructured":"Metzler, K. D., Goosmann, C., Lubojemska, A., Zychlinsky, A. & Papayannopoulos, V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep. 8, 883\u2013896 (2014).","journal-title":"Cell Rep."},{"key":"50747_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos, V., Metzler, K. D., Hakkim, A. & Zychlinsky, A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677\u2013691 (2010).","journal-title":"J. Cell Biol."},{"key":"50747_CR15","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.celrep.2018.02.067","volume":"22","author":"H Kambara","year":"2018","unstructured":"Kambara, H. et al. Gasdermin D exerts anti-inflammatory effects by promoting neutrophil death. Cell Rep. 22, 2924\u20132936 (2018).","journal-title":"Cell Rep."},{"key":"50747_CR16","doi-asserted-by":"crossref","unstructured":"Sollberger, G. et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci. Immunol. 3, eaar6689 (2018).","DOI":"10.1126\/sciimmunol.aar6689"},{"key":"50747_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146\u2013153 (2016).","journal-title":"Nat. Med."},{"key":"50747_CR18","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","volume":"74","author":"JS Knight","year":"2015","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice. Ann. Rheum. Dis. 74, 2199\u20132206 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"50747_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2016.00227","volume":"7","author":"Y Kusunoki","year":"2016","unstructured":"Kusunoki, Y. et al. Peptidylarginine deiminase inhibitor suppresses neutrophil extracellular trap formation and MPO-ANCA production. Front. Immunol. 7, 227 (2016).","journal-title":"Front. Immunol."},{"key":"50747_CR20","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI76009","volume":"124","author":"OE Sorensen","year":"2014","unstructured":"Sorensen, O. E. et al. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses. J. Clin. Invest. 124, 4539\u20134548 (2014).","journal-title":"J. Clin. Invest."},{"key":"50747_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C. et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 65, 1\u201311 (2013).","journal-title":"Arthritis Rheum."},{"key":"50747_CR22","doi-asserted-by":"publisher","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","volume":"114","author":"A Schreiber","year":"2017","unstructured":"Schreiber, A. et al. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc. Natl. Acad. Sci. USA 114, E9618\u2013E9625 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50747_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","volume":"15","author":"D Nakazawa","year":"2019","unstructured":"Nakazawa, D., Masuda, S., Tomaru, U. & Ishizu, A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat. Rev. Rheumatol. 15, 91\u2013101 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"50747_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1681\/ASN.V83386","volume":"8","author":"R Kettritz","year":"1997","unstructured":"Kettritz, R., Jennette, J. C. & Falk, R. J. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J. Am. Soc. Nephrol. 8, 386\u2013394 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"50747_CR25","doi-asserted-by":"publisher","first-page":"684886","DOI":"10.3389\/fphar.2021.684886","volume":"12","author":"D Nakazawa","year":"2021","unstructured":"Nakazawa, D. & Kudo, T. Novel therapeutic strategy based on neutrophil subset and its function in autoimmune disease. Front. Pharm. 12, 684886 (2021).","journal-title":"Front. Pharm."},{"key":"50747_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1681\/ASN.2021081112","volume":"33","author":"U Jerke","year":"2022","unstructured":"Jerke, U. et al. Targeting cathepsin C in PR3-ANCA vasculitis. J. Am. Soc. Nephrol. 33, 936\u2013947 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"50747_CR27","doi-asserted-by":"publisher","first-page":"12415","DOI":"10.1074\/jbc.RA118.001922","volume":"293","author":"S Seren","year":"2018","unstructured":"Seren, S. et al. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis. J. Biol. Chem. 293, 12415\u201312428 (2018).","journal-title":"J. Biol. Chem."},{"key":"50747_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos, S., Gupta, A. & Ravetch, J. V. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 20, 633\u2013643 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"50747_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/cyto.a.23169","volume":"91","author":"S Masuda","year":"2017","unstructured":"Masuda, S. et al. Measurement of NET formation in vitro and in vivo by flow cytometry. Cytom. A 91, 822\u2013829 (2017).","journal-title":"Cytom. A"},{"key":"50747_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06263-5","volume":"9","author":"E Neubert","year":"2018","unstructured":"Neubert, E. et al. Chromatin swelling drives neutrophil extracellular trap release. Nat. Commun. 9, 3767 (2018).","journal-title":"Nat. Commun."},{"key":"50747_CR31","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","volume":"174","author":"MA Little","year":"2009","unstructured":"Little, M. A. et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am. J. Pathol. 174, 1212\u20131220 (2009).","journal-title":"Am. J. Pathol."},{"key":"50747_CR32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2174\/1389203717666160909125004","volume":"18","author":"W Shang","year":"2017","unstructured":"Shang, W. & Wang, Z. The update of NGAL in acute kidney injury. Curr. Protein Pept. Sci. 18, 1211\u20131217 (2017).","journal-title":"Curr. Protein Pept. Sci."},{"key":"50747_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2022.104754","volume":"125","author":"S Masuda","year":"2022","unstructured":"Masuda, S. et al. Phorbol 12-myristate 13-acetate stimulation under hypoxia induces nuclear swelling with DNA outflow but not extracellular trap formation of neutrophils. Exp. Mol. Pathol. 125, 104754 (2022).","journal-title":"Exp. Mol. Pathol."},{"key":"50747_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12016-020-08800-x","volume":"61","author":"HH Yu","year":"2021","unstructured":"Yu, H. H., Yang, Y. H. & Chiang, B. L. Chronic granulomatous disease: a comprehensive review. Clin. Rev. Allergy Immunol. 61, 101\u2013113 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"50747_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13336","volume":"33","author":"L Giannetti","year":"2020","unstructured":"Giannetti, L. et al. Papillon-lefevre syndrome: Oral aspects and treatment. Dermatol. Ther. 33, e13336 (2020).","journal-title":"Dermatol. Ther."},{"key":"50747_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/icb.2010.115","volume":"89","author":"CE Andoniou","year":"2011","unstructured":"Andoniou, C. E., Fleming, P., Sutton, V. R., Trapani, J. A. & Degli-Esposti, M. A. Cathepsin C limits acute viral infection independently of NK cell and CD8+ T-cell cytolytic function. Immunol. Cell Biol. 89, 540\u2013548 (2011).","journal-title":"Immunol. Cell Biol."},{"key":"50747_CR37","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki, E. et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology 53, 2306\u20132309 (2014).","journal-title":"Rheumatology"},{"key":"50747_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates, M. et al. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann. Rheum. Dis. 75, 1583\u20131594 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"50747_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/14397595.2018.1500437","volume":"29","author":"M Harigai","year":"2019","unstructured":"Harigai, M. et al. 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis. Mod. Rheumatol. 29, 20\u201330 (2019).","journal-title":"Mod. Rheumatol."},{"key":"50747_CR40","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.lpm.2015.02.019","volume":"44","author":"O Flossmann","year":"2015","unstructured":"Flossmann, O. Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. Presse Med. 44, e251\u2013e257 (2015).","journal-title":"Presse Med."},{"key":"50747_CR41","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","volume":"28","author":"DRW Jayne","year":"2017","unstructured":"Jayne, D. R. W. et al. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated Vasculitis. J. Am. Soc. Nephrol. 28, 2756\u20132767 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"50747_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne, D. R. W., Merkel, P. A., Schall, T. J. & Bekker, P. Avacopan for the treatment of ANCA-associated Vasculitis. N. Engl. J. Med. 384, 599\u2013609 (2021).","journal-title":"N. Engl. J. Med."},{"key":"50747_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/acr2.11412","volume":"4","author":"WD Soulsby","year":"2022","unstructured":"Soulsby, W. D. Journal club review of \u201cAvacopan for the treatment of ANCA-associated Vasculitis\u201d. ACR Open Rheumatol. 4, 558\u2013561 (2022).","journal-title":"ACR Open Rheumatol."},{"key":"50747_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1189\/jlb.5A1015-489R","volume":"100","author":"H Roberts","year":"2016","unstructured":"Roberts, H. et al. Characterization of neutrophil function in Papillon-Lefevre syndrome. J. Leukoc. Biol. 100, 433\u2013444 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"50747_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102150","volume":"50","author":"R Kuhikar","year":"2021","unstructured":"Kuhikar, R. et al. Neutrophils generated in vitro from hematopoietic stem cells isolated from apheresis samples and umbilical cord blood form neutrophil extracellular traps. Stem. Cell Res. 50, 102150 (2021).","journal-title":"Stem. Cell Res."},{"key":"50747_CR46","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2007-03-080457","volume":"110","author":"C Kantari","year":"2007","unstructured":"Kantari, C. et al. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 110, 4086\u20134095 (2007).","journal-title":"Blood"},{"key":"50747_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623\u2013625 (2009).","journal-title":"Nat. Med."},{"key":"50747_CR48","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ki.2015.202","volume":"88","author":"KM O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan, K. M. et al. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Kidney Int. 88, 1030\u20131046 (2015).","journal-title":"Kidney Int."},{"key":"50747_CR49","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim, A. et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. USA 107, 9813\u20139818 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"50747_CR50","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1681\/ASN.2013060606","volume":"25","author":"D Nakazawa","year":"2014","unstructured":"Nakazawa, D. et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J. Soc. Am. Nephrol. 25, 990\u2013997 (2014).","journal-title":"J. Soc. Am. Nephrol."},{"key":"50747_CR51","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.bmc.2014.12.056","volume":"23","author":"TL Hwang","year":"2015","unstructured":"Hwang, T. L., Wang, W. H., Wang, T. Y., Yu, H. P. & Hsieh, P. W. Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3. Bioorg. Med. Chem. 23, 1123\u20131134 (2015).","journal-title":"Bioorg. Med. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50747-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:50:08Z","timestamp":1724406608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50747-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50747"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50747-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3221971\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.S., W.S., T.N., and Y.T. are employees of Alivexis, Inc. Y.N., S.M., and A.I. were given research funds from Alivexis, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6519"}}